CIK 0001100682 · Large accelerated filer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sign in to watch- Ticker
- CRL
- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 27
- Entity type
- operating
- EIN
- 061397316
- Phone
- 781-222-6000
- Business address
- 251 BALLARDVALE ST, WILMINGTON, MA, 01887
- Former names
- CHARLES RIVER LABORATORIES INTERNATIONAL INC, CHARLES RIVER LABORATORIES HOLDINGS INC
- 4 Open-market sale EVP, Corp Strategy & Develop sold 9,128 shares at an average $173.48 ($1,583,522)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market buy Director bought 1,000 shares at $198.79 ($198,786)
- 4 Open-market sale Corporate Executive VP & CCO sold 5,763 shares at $217.24 ($1,251,954)
- 4 Open-market sale CSVP&Chief Accounting Officer sold 1,471 shares at $216.54 ($318,530)
- 4 Gift Chairman, President and CEO gave 2,500 shares (gift)
- 4 Open-market sale EVP, Corp Strategy & Develop sold 700 shares at $216.52 ($151,564)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- 4 Grant or award Director acquired 95 shares (grant or award)
- 4 Grant or award CSVP&Chief Accounting Officer acquired 1,528 shares (grant or award)
- 4 Grant or award Director acquired 338 shares (grant or award)
- 4 Shares withheld for taxes EVP, Corp Strategy & Develop gave up 532 shares (to pay taxes)
- 4 Shares withheld for taxes CSVP&Chief Accounting Officer gave up 96 shares (to pay taxes)
Page 16 of 123 · 2,446 filings